Zimmer Biomet (ZBH): Hotchkis & Wiley Capital Management LLC added to its stake +114K shares
Hotchkis & Wiley Capital Management LLC added to its stake in Zimmer Biomet, per its Q4 2025 13F.
- 1.72M
- Shares reported · +114K vs prior quarter
- 0.46%
- Disclosed portfolio weight
- $155M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 9, 2025Federal contract · $61K obligatedDepartment of Defense awarded Zimmer Biomet: $61K obligated to date
- Jan 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, Mark Bezjak, a named executive officer in the 2025 proxy statement of Zimmer Biomet Holdings, Inc. (the “Company”), informed the Company that he will resign his employment, including all officer positions with the Company and its affiliates, effective as of January 16, 2026, to pursue another business opportunity.”
- Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 12, 2026InsiderOfficer sold ~$96K of ZBH shares in the open market
- Feb 17, 20265% stakeHARRIS ASSOCIATES L P reported a passive stake (13G) of 6.2%
What came next
- Mar 2, 2026Federal contract · $111K obligatedDepartment of Defense awarded Zimmer Biomet: $111K obligated to date
- Mar 12, 2026InsiderOfficer sold ~$251K of ZBH shares in the open market
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 15, 2026FDAFDA device clearance: Comprehensive Reverse Shoulder - HA Glenosphere Baseplates
- Apr 22, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the “Company”) of his intention to resign from the position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity.”
- Apr 27, 2026FDAFDA device clearance: Avenir® Müller Stem; Avenir Complete Hip System
- Apr 28, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 11, 2026FDARecall: Brand Name: Persona Revision Product Name: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/…
- May 15, 20265% stakeT. Rowe Price Associates, Inc. reported a passive stake (13G) of 4.1%
- May 19, 2026FDAFDA device clearance: Taperloc® Complete Hip Stem
- May 20, 2026FDARecall: Off-Axis Comprehensive Shoulder System, Medium, Augment, Off-Axis, Reamer Guide Model/Catalog Number: 110040241
- May 20, 2026FDARecall: Off-Axis Alliance Glenoid, Right, 4-Peg, Augment, Reamer Guide, Model/Catalog Number: 110040476
- May 20, 2026FDARecall: Off-Axis Alliance Glenoid, Left, 4-Peg, Augment, Reamer Guide, Model/Catalog Number: 110040444
- May 20, 2026FDARecall: Off-Axis Comprehensive Shoulder System Small, Augment, Off-Axis, Reamer Guide, Model/Catalog Number: 110040240
- May 20, 2026FDARecall: Off-Axis Comprehensive Shoulder System, Large, Augment, Off-Axis, Reamer Guide Model/Catalog Number: 110040242
- May 28, 2026FDAFDA device clearance: Zimmer® Persona® Personalized Knee System
- May 29, 2026Insider · 1 personInsiders: 2 sales (~$413K)
- Jun 2, 2026FDAFDA device clearance: Pectus Blu System
- Jun 9, 2026FDARecall: Brand Name: Sterile Tourniquet Hoses Product Name: A.T.S¿ 4000 TS Tourniquet Systems Single Hose with CPC Connectors Model/Catalog Number: 60-4009-101-00 Softw…
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Zimmer Biomet
For Zimmer Biomet, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZBH page.
How this filing works
Explore the data
Common questions
What does this filing report about Zimmer Biomet (ZBH) stock?
Hotchkis & Wiley Capital Management LLC added to its stake in Zimmer Biomet, per its Q4 2025 13F. Now 1.72M shares, $155M reported value, 0.46% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 17, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Zimmer Biomet recently?
For Zimmer Biomet, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the ZBH page.
Does this mean ZBH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Zimmer Biomet
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordSep 29, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 144Sep 11, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 144Sep 4, 2026
Everything OQRO holds on this company is on its ZBH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
